Pharma giant bets $2.3B on massive new Houston campus
Sources (10)
- Bristol Myers Squibb selects Generation Park for new $2.3B manufacturing campus Community Impact · 7d ago
- Houston's Generation Park Lands Another $2.3B Pharma Manufacturing Investment Bisnow · 7d ago
- Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas Bristol Myers Squibb · 7d ago
- Houston lands $2.3 billion life science manufacturing campus axios.com · 7d ago
- Bristol Myers Squibb to build $2.3 billion Houston campus qz.com · 7d ago
- Bristol Myers to build $2.3 billion manufacturing site in Houston Reuters · 7d ago
- Major pharmaceutical company plans $2.3B Houston manufacturing campus, 500 jobs KHOU · 7d ago
- Bristol Myers Squibb commits to Houston with $2.3 billion manufacturing site The Business Journals · 7d ago
- Bristol Myers Squibb Advances U.S. Manufacturing Investment with New $2.3 Billion Campus in Houston, Texas Bristol Myers Squibb · 7d ago
- Pharma giant bets $2.3B on massive new Houston campus chron.com · 7d ago broke it first
How fast it spread
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Credit card issuer Synchrony partners with OpenAI for ChatGPT shopping
Credit card issuer Synchrony has partnered with OpenAI to bring store cards and shopping offers into ChatGPT.
The Surprising Reason This Biotech Plummeted 69%
EyePoint Pharmaceuticals shares cratered following a late-stage trial setback for its flagship eye disease drug.
China's recovery sputters as consumption, output lose steam
China's economic recovery is losing momentum as retail sales, output, and investment slow down.
Alibaba to Sell Videogame Business for at Least $1.5 Billion
Alibaba moves to sell its videogame business to prioritize artificial intelligence and e-commerce.
Big investors hunt for tomorrow's AI winners as capex angst fades
Major investors are shifting focus toward emerging artificial intelligence opportunities as capital expenditure concerns diminish.
Private credit under strain as troubled loans swell
Private credit faces high stress levels and troubled loans, while industry leaders debate systemic risks.